Pentostatin (2'-deoxycoformycin) for the treatment of lymphoid neoplasms.
Ho
A D
AD
Department of Internal Medicine, University of Heidelberg, F.R.G.
Thaler
J
J
Willemze
R
R
Lauria
F
F
Mandelli
F
F
Stryckmans
P
P
de Cataldo
F
F
Baccarani
M
M
Peetermans
M E
ME
de Witte
T
T
D004341:Drug Evaluation; D005060:Europe; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D015463:Leukemia, Prolymphocytic / Q000188:drug therapy; D015461:Leukemia, Prolymphocytic, T-Cell / Q000188:drug therapy; D009182:Mycosis Fungoides / Q000188:drug therapy*; D015649:Pentostatin / Q000627:therapeutic use*; D011446:Prospective Studies; D012074:Remission Induction; D012751:Sezary Syndrome / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*
D015649:Pentostatin